We also continue to strengthen our portfolio by means of strategic acquisitions and are prioritizing the improvement of several promising oncology candidates with the prospective to increase the therapy of advanced cancers. For much more details about our oncology clinical trials, pay a visit to /clinicaltrials. The collaboration has reportedly...

  • 2022-10-21